Excessive sugar intake fuels metabolic and hormonal changes, increasing the risk of both diabetes and cancer. High sugar ...

Told he had liver cancer, Roger Jackson feared the worst. ‘I thought, “Here we go, I’m going to die”,’ says the 80-year-old great-grandfather and retired sales manager. Patients in Roger’s situation ...

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new study led by Weill Cornell Medicine suggests a surprising way to stop it from ...

Colon cancer still feels like a distant worry for many people, but gastroenterologists repeatedly say the same thing, the ...

Residents of Scott County, Virginia, are sharing their concerns after several children within the county have been diagnosed ...

Health leaders believe the UK could face its worst flu season to date - with some hospitals already declaring critical ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent ...

Kelonia Therapeutics' KLN-1010 has shown promising early results in a phase 1 trial for relapsed or refractory multiple ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read more on GILD stock here.

Understanding how cancer develops, preventing chronic inflammation, supporting the mitochondria, and adjusting lifestyle habits – all help reduce risks and strengthen the body’s natural defenses.